The impact of antigen density and antibody affinity on antibody dependent cellular cytotoxicity: Relevance for immunotherapy of carcinomas

British Journal of Cancer

Volumn 78, Issue 4, 1998, Pages 478-483

  Velders, M P ^a,b   Van Rhijn, C M ^a   Oskam, E ^a   Fleuren, G J ^a   Warnaar, S O ^a   Litvinov, S V ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LOYOLA UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Affinity; Antibody dependent cellular cytotoxicity; Ep CAM; Immunotherapy; Monoclonal antibody

Indexed keywords

CD18 ANTIGEN; COMPLEMENTARY DNA; MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANTIBODY AFFINITY; ARTICLE; CANCER IMMUNOTHERAPY; CELL KINETICS; CELL MEDIATED CYTOTOXICITY; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0031856404     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.518     Document Type: Article

References (30)

1. Adams DO, Hall T, Steplewski Z and Koprowski H (1984) Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis. Proc Natl Acad Sci USA 81: 3506-3510
2. Capone PM, Papsidero LD and Chu TM (1984) Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. J Natl Cancer Inst 72: 673-677
3. Edwards BS, Nolla HA and Hoffman RR (1992) Resolution of adhesion- and activation-associated components of monoclonal antibody-dependent human NK cell-mediated cytotoxicity. Cell Immunol 144: 55-68
4. Fleuren GJ, Goner A, Kuppen PJK, Litvinov SV and Warnaar SO (1945) Tumor heterogeneity and immunotherapy of cancer. Immunol Rev 145: 91-122
5. Fogler WK, Klinger MR, Abraham KG, Gottlinger HG, Riethmüller G and Daddona PE (1988) Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen. Cancer Res 48: 6303-6308
6. Gorter A, Block VT, Haasnoot WHB, Ensink NG, Daha MR and Fleuren GJ (1996) Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Lab Invest 74: 1039-1049
7. Hagan PL, Halpern SE, Dillman RO, Shawler DL, Johnson DE, Chen A, Krishnan L, Frincke J, Bartholomew RM and David GS (1986) Tumor size: effect on monoclonal antibody uptake in tumor models. J Nucl Med 27: 422-427
8. Herlyn D and Koprowski H (1982) IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells. Proc Natl Acad Sci USA 79: 4761-1765
9. Herlyn D, Powe J, Ross AH, Herlyn M and Koprowski H (1985) Inhibition of human tumor growth by IgG2a monoclonal antibodies correlates with antibody density on tumor cells. J Immunol 134: 1300-1304
10. Johnston SC, Dustin ML, Hibbs ML and Springer TA (1990) On the species specificity of the interaction of LFA-1 with intercellular adhesion molecules. J Immunol 145: 1181-1187
11. Kumar S, Vinci JM, Pytel BA and Baglioni C (1993) Expression of messenger RNAs for complement inhibitors in human tissues and tumors. Cancer Res 53: 348-353
12. Kushner BH and Cheung NK (1992) Absolute requirement of CD11/CD18 adhesion molecules. FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood 79: 1484-1490
13. Liesveld JL, Frediani KE, Winslow JM, Duersi RE and Abboud CN (1991) Cytokine effects and role of adhesive proteins and Fc receptors in human macrophage-mediated antibody dependent cellular cytotoxicity. J Cell Biochem 45: 381-390
14. Litvinov SV (1995) Ep-CAM: a homophilic cell-cell adhesion molecule with EGF-like domains. Trends Glycosci Glycotechn 7: 261-271
15. Litvinov SV, Velders MP, Bakker HAM, Fleuren GJ and Warnaar SO (1994a) Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125: 437-446
16. Litvinov SV, Bakker HA, Gourevitch MM, Velders MP and Warnaar SO (1994b) Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesion. Cell Adhes Commun 2: 417-128
17. Mentzer SJ, Barbosa JA, Strominger JL, Biro PA and Burakoff SJ (1986) Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. J Immunol 137: 408-412
18. Morgenstern JP and Land H (1990) A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 18: 1068
19. Orlandi R, Figini M, Tomassetti A, Canevari S and Colnaghi MI (1992) Characterization of a mouse-human chimeric antibody to a cancer-associated antigen. Int J Cancer 52: 588-593
20. Pak KY, Nedelman MA, Fogler WE, Tam SH, Wilson F, Van Haarlem LJ, Colognola R, Warnaar SO and Daddona PE (1991) Evaluation of the 323/A3 monoclonal antibody and the use of technetium-99m-labeled 323/A3 Fab' for the detection of panadenocarcinoma. Int J Rad Appl Instrum 18: 483-497
21. Riethmüller G, Schneider-Gadicke E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Pichlmaier H, Hirche H and Pichlmayr R (1994) Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. Lancet 343: 1177-1183
22. Shetye J, Frodin JE, Christensson B, Grant C, Jacobsson B, Sundelius S, Sylven M and Mellstedt H (1988) Immunohistochemical monitoring of metastatic colorectal carcinoma in patients treated with monoclonal antibodies (MAb 17-1A). Cancer Immunol Immunother 27: 154-162
23. Steplewski Z, Sun LK, Shearman CW, Ghrayeb J, Daddona P and Koprowski H (1988) Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity. Proc Natl Acad Sci USA 85: 4852-4856
24. Sun LK, Curtis P, Rakowicz Szulczynska E, Ghrayeb J, Chang N, Morrison SL and Koprowski H (1987) Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. Proc Natl Acad Sci USA 84: 214-218
25. Szala S, Frochlich M, Scollon M, Kasai Y, Steplewski Z, Koprowski H and Linnenbach AJ (1990) Molecular cloning of cDNA for the carcinoma-associated antigen GA733-2. Proc Natl Acad Sci USA 87: 3542-3546
26. Takahashi H, Nakada T, Nakaki M and Wands JR (1995) Inhibition of hepatic metastases of human colon cancer in nude mice by a chimeric SF-25 monoclonal antibody. Gastroenterology 108: 172-182
27. Velders MP, Litvinov SV, Warnaar SO, Gorter A, Fleuren GJ, Zurawski VR Jr and Coney LR (1994) New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency. Cancer Res 54: 1753-1759
28. Velders MP, van Rhijn CM, Briaire IH, Fleuren GJ, Warnaar SO and Litvinov SV (1995) Immunotherapy with low and high affinity monoclonal antibodies 17-1A and 323/A3 in a nude mouse xenograft carcinoma model. Cancer Res 55: 4398-4403
29. Velders MP, van Rhijn CM, Cornelissen IMHA, van Muijen GNP, Briaire IH, Fleuren GJ, Warnaar SO and Litvinov SV (1996) The role of antibody affinity in tumor immunotherapy evaluated in in vivo models for minimal residual disease. J Immunother 19: 245-256
30. Webb DSA, Mostowski HS and Gerrard TL (1991) Cytokine-induced enhancement of ICAM-1expression results in increased vulnerability of tumor cells to monocyte-mediated lysis. J Immunol 146: 3682-3686